Catalyst Wire Dossier Catalyst Wire Dossier

Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine, covering 2025-09-11 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults [Phase 1]

See pricing